Parameters assessing neurological status in malignant glioma patients: Prognostic value for survival and relapse-free time

British Journal of Neurosurgery

Volumn 22, Issue 4, 2008, Pages 557-562

  Martinez, R ^a,c   Volter C ^b   Behr, R ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Functional; Malignant glioma; Neurological; Outcome; Survival

Indexed keywords

CARMUSTINE; IMATINIB; TEMOZOLOMIDE;

ACCURACY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; NEUROLOGICAL PERFORMANCE SCALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RISK FACTOR; SAWAYA FUNCTIONAL GRADE; SURVIVAL TIME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; PROGNOSIS; RECURRENCE; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 52749087909     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690802166424     Document Type: Article

References (30)

1. Kleihues P, Ohgaki H. Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro-oncol 1999;1:44-51.
2. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection and survival. J Neurosurg 2001;95:190-8.
3. Shapiro WR, Green SB, Burger PC, et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989;71:1-9.
4. Scott JN, Rewcastle NB, Brasher PMA, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population based study. Ann Neurol 1999;46:183-8.
5. Chandler KL, Prados MD, Malec M, Wilson CB. Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993;32:716-20.
6. Black PM, Alexander E, 3rd, Martin C, et al. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 1999;45:423-31.
7. Hammoud MA, Ligon BL, elSouki R, et al. Use of intraoperative ultrasound for localizing tumors and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg 1996;84:737-41.
8. Hentschel SJ, Sawaya R. Optimizing outcomes with maximal surgical resection of malignant gliomas. Cancer Control 2003;10:109-14.
9. Chan TA, Weingart JD, Parisi M, et al. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys 2005;62:1133-9.
10. Westphal M, Hilt DC, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-oncol 2003;5(2):79-88.
11. Brell M, Ibanez J, Caral L, Ferrer E. Factors influencing surgical complications of intra-axial brain tumours. Acta Neurochir (Wien) 2000;142:739-50.
12. Sawaya R, Hammoud M, Schoppa D, et al. Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998;42:1044-55.
13. Central Brain Tumor Registry of the United States. Statistical report: primary brain tumors in the United States 1998-2002. Available at: http://www.cbtrus.org/reports//2005-2006/2006report.pdf (accessed 18 May 2007).
14. Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 1999;42:227-31.
15. Metcalfe SE, Grant R. Biopsy versus resection for malignant glioma. Cochrane database Syst Rev 3: CD002034, 2001.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
17. Stupp R, Dietrich PY, Ostermann Kraljevic S, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002;20:1375-82.
18. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303:1323-9.
19. Giese A, Bjerkvig R, Berens ME, Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003;21:1624-36.
20. Kelly PJ, Daumas-Duport C, Kispert DB, et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 1987;66:865-74.
21. Ammirati M, Vick N, Liao YL, Ciric I, Mikhael M. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 1987;21:201-6.
22. Fadul C, Wood J, Thaler H, et al. Morbidity and mortality of craniotomy for excision of supratentorial gliomas. Neurol 1988;38:1374-9.
23. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 1994;34:45-60.
24. Ciric I, Ammirati M, Vick N, Mikhael M. Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 1987;21:21-6.
25. Nitta T, Sato K. Prognostic implications of the extent of tumor resection in patients with intracranial malignant gliomas. Cancer 1995;75:2727-31.
26. Salcman M. The value of cytoreductive surgery. Clin Neurosurg 1994;41:464-88.
27. Kelly PJ, Kall BA, Goerss SJ. Results of computed tomography-based computer-assisted stereotactic resection of metastatic intracranial tumors. Neurosurgery 1988;22:7-17.
28. Vives KP, Piepmeier JM. Complications and expected outcome of glioma surgery. J Neurooncol 1999;42:289-302.
29. Kreth FW, Warnke PC, Ostertag CB. The limited value of cytoreductive surgery in elderly patients with malignant glioma. Neurosurgery 1994;35:144.
30. Latif AZ, Signorini D, Gregor A, et al. Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial. J Neurol Neurosurg Psychiatry 1998;64:747-50.